Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner ‘Quality and Outcomes Framework’

M. Ashworth; D. Lloyd; R. S. Smith; A. Wagner; G. Rowlands
March 2007
Journal of Public Health;Vol. 29 Issue 1, p40
Academic Journal
We aimed to study the relationship between the prescribing of lipid-lowering medication, social deprivation and other general practice characteristics. We conducted a cross-sectional survey of all general practices in England, 2004–05. For each practice, the following variables were obtained: standardized cost and volume data for lipid-lowering medication, descriptors of general practices, Index of Multiple Deprivation, 2004, ethnicity data from the 2001 Census and Quality and Outcomes Framework data. A regression model was constructed which explained 34.5% of the variation in statin prescribing by general practitioners. The most powerful predictors were higher social deprivation, higher prevalence of coronary heart disease and achievement of cholesterol targets for diabetics. Negative regression coefficients were demonstrated for the proportion of elderly patients in the practice and, to a lesser extent, for the proportion of south Asian and Afro-Caribbean patients. In conclusion, contrary to previous local studies, we found that statin prescribing was higher in more deprived communities, even after adjustment for increased disease prevalence and practice variables associated with deprivation. Statin prescribing was also independently associated with success at achieving cholesterol targets in established disease (secondary prevention). However, our findings suggest under-prescribing of statins to the elderly and possibly also to ethnic minorities.


Related Articles

  • WHAT I WILL DO NOW. Brown, Pam // Pulse;2/18/2009, Vol. 69 Issue 5, p26 

    The article discusses the significant changes in diet and physical activity for patient with hyperlipidemia, hypertension or diabetes in Great Britain. It also discusses the usage of stanols and sterols in treating those patients who are incompetent for statin therapy. GPs also warn patients to...

  • The impact of cost-sharing schemes on drug compliance in Italy: evidence based on quantile regression. Atella, Vincenzo; Kopinska, Joanna // International Journal of Public Health;Apr2014, Vol. 59 Issue 2, p329 

    Objectives: In this article we investigate the causal effect of cost-sharing schemes on compliance with statins in a quantile regression framework. Methods: We use the health search CSD-LPD data, a longitudinal observational dataset containing computer-based patient records collected by Italian...

  • Generic statins save £2 billion.  // GP: General Practitioner;6/16/2006, p3 

    The article reports that general practitioners can dramatically cut NHS costs in England by using generic statins as first-line therapy for the majority of patients with hyperlipidaemia. About 85 percent of statin prescriptions in England are for simvastatin or atorvastatin. Most atorvastatin...

  • Tips from Other Journals. MOON, KENNETH T.; WALLING, ANNE D.; JOHNSON, GREG; CRAWFORD-FAUCHER, AMY // American Family Physician;2/1/2010, Vol. 81 Issue 3, p333 

    The article offers information on several studies of interest to family physicians in the U.S., published in various periodicals in 2009. They include the contribution of fluvastatin during perioperative period to enhanced postoperative outcomes in patients who are going through noncardiac...

  • Leader: Commissioning is matter of faith.  // GP: General Practitioner;2/3/2006, p43 

    The article reports that the long-awaited Great Britain Department of Health guidance says that general practitioners should be able to keep at least 70 percent of savings. National Health Service patients are being promised access to new expensive treatments, but PCTs are not receiving extra...

  • Registrar: MRCGP Exam Update - Lowering cholesterol levels. Newson, Louise // GP: General Practitioner;3/10/2006, p64 

    This article presents information on several studies on the benefits of lowering cholesterol levels. A study found that although general practitioners believed that 80 per cent of their patients were being successfully treated with statins, only 65 per cent of their patients were reaching target...

  • Confusion over statins for diabetes. Pedder, Cato // Pulse;6/14/2004, Vol. 64 Issue 24, p4 

    Reports that the British Department of Health has refused to give new advice on prescribing statins to diabetes patients until an economic analysis is completed. Confusion of general practitioners over statin prescribing; Prescription of statins to type 2 diabetes patients regardless of their...

  • Overworked and under-resourced GPs are missing Government targets for statins. Kelly, Brian // Pulse;9/2/2002, Vol. 62 Issue 33, p19 

    Focuses on the failure of general practitioners in accomplishing the targets set by the government for statins in Great Britain. Hindrance of workload pressures and financial problems in meeting the responsibilities; Lack of funding for statins; Prescription of statins in primary care.

  • Confusion over statin dispute 'risks patient trust.  // GP: General Practitioner;7/7/2014, p50 

    The article reports that the benefits and harms of statin treatment risks were undermining confidence in the treatment decisions of general practitioners (GPs) according to a survey conducted by "General Practitioner", and some GPs and patients were confused by the dispute about statin treatment.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics